Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
More on Expansion
Xplorer Capital, Futury Venture lead $22m round for Wingcopter
Germany-based delivery drone developer is also backed by Hessen Kapital via Hessen Kapital III
Toscafund leads €25m round for Elinvar
Existing investors Goldman Sachs Growth, Ampega and Finleap also back the round
BGF invests £4m in CSN
For the year ending on 31 March 2020, the company generated £1.6m in EBITDA, from revenues of £27.1m
Lightspeed leads $20m Wintermute series-B
Lightspeed led the company's series-A funding round in June 2020, following another round in January
Latest News
Sponsor Capital acquires and merges Likeit, Nepton
Merged company will have combined revenues of around €8m in 2020, and employ over 50 staff.
Holland Capital invests in Cards PLM Solutions
Digitalisation and project life cycle management business intends to expand in DACH and Benelux
Sinergia Venture Fund holds €30m first close
Fund invests in pre-series-A and series-A rounds to support the growth of startups operating across a large variety of sectors
Octopus to launch £100m healthcare-focused fund
In conjunction with the announcement, the firm has hired an investment team from TenX Health